gefitinib has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, N; Mao, H; Qiu, A; Shi, Y; Wang, L; Xiong, C; Xu, L; Zang, X; Zhuang, S | 1 |
1 other study(ies) available for gefitinib and Encapsulating Peritoneal Sclerosis
| Article | Year |
|---|---|
Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal Fibrosis.
Topics: Animals; Disease Progression; ErbB Receptors; Gefitinib; Male; Peritoneal Fibrosis; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Time Factors; Transforming Growth Factor beta1 | 2016 |